Episode 326

You are being lied to about testosterone. Not maliciously, not by any single person, but by a cultural narrative that has been assembled over decades from fragments of misunderstood science, pharmaceutical marketing, evolutionary psychology oversimplification, and the desperate human need to explain male behavior through a single, clean, powerful variable. The lie goes something like this: testosterone makes men aggressive. Testosterone explains male violence. Testosterone is why men are the way they are. And if your testosterone is low, you are somehow less of a man. If it is high, you are either a peak specimen or a dangerous liability, depending on who is telling the story.

Both ends of that story are wrong. And the cost of believing them — personally, relationally, culturally — is enormous.

I am Vladislav Davidzon, and this is Resilient Wisdom. Today we are going deep into the actual science of testosterone and behavior. Not the podcast-bro version. Not the pharmaceutical company version. Not the gender-studies-dismissal version. The research. What it shows, what it does not show, where the genuine uncertainty lives, and why the gap between the science and the mythology matters more than most people are willing to admit.

We are going to spend time with real researchers — Robert Sapolsky at Stanford, Allan Mazur at Syracuse, Lee Gettler at Notre Dame, Christoph Eisenegger at Zurich, Abraham Morgentaler at Harvard, and others who have spent careers building an actual evidence base rather than confirming preexisting beliefs. We are going to look at case studies that illuminate how hormonal dynamics play out in real human lives. And at the end, I am going to give you a framework I call the Hormonal Literacy Protocol — a systematic way of understanding and working with your own hormonal landscape that is grounded in evidence rather than mythology.

This is episode 326. And I want to be honest with you upfront: this conversation is going to challenge some things you probably believe. That is the point. Let us begin.


Part One: What Testosterone Actually Is — The Biology Without the Mythology

Let us start at the foundation, because most conversations about testosterone skip it entirely and jump straight to behavioral claims. To understand what testosterone does in behavior, you need to understand what it is biochemically and how it operates within a larger system.

Testosterone is a steroid hormone — meaning it is derived from cholesterol — belonging to the androgen family. In men, it is produced primarily in the Leydig cells of the testes, with a smaller but meaningful contribution from the adrenal glands. In women, the ovaries and adrenal glands produce testosterone in smaller but functionally important amounts. The hypothalamus releases gonadotropin-releasing hormone (GnRH), which signals the pituitary to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn signal the testes to produce testosterone. This is the HPG axis — the hypothalamic-pituitary-gonadal axis — and it operates as a sophisticated feedback loop, not a simple on-off switch.

In adult men, total testosterone levels typically range from 300 to 1000 nanograms per deciliter, though this range varies somewhat by laboratory and reference population. But total testosterone tells an incomplete story. Roughly 44% of circulating testosterone is tightly bound to sex hormone-binding globulin (SHBG) and is biologically inactive. Another 50-54% is loosely bound to albumin and is partially available to tissues. Only about 1-3% is free testosterone — fully unbound and available to enter cells and bind to androgen receptors. It is this free fraction, and the loosely albumin-bound fraction together (often called bioavailable testosterone), that most directly drives androgenic effects.

Here is something that fundamentally changes how you should think about testosterone levels: androgen receptor density and sensitivity vary enormously between individuals. Two men can have identical total testosterone levels and radically different androgenic responses based on how many androgen receptors their cells express and how sensitive those receptors are. This is partly genetically determined and partly influenced by behavioral and lifestyle factors. The number on your lab report is one data point in a complex system, not a verdict.

Testosterone follows a diurnal rhythm in healthy men — it peaks in the early morning hours, typically between 7 and 10 AM, and declines through the day, reaching its nadir in the late afternoon and evening. This is why morning testing is the clinical standard. But testosterone also fluctuates day-to-day in the same individual by 20-30% based on sleep quality, stress, recent physical activity, sexual activity, competitive experiences, and social context. A single measurement tells you less than you think.

The critical point that most popular discussions miss is this: testosterone does not simply cause behavior in a one-directional way. The relationship is bidirectional and deeply contextual. Testosterone influences behavior, yes — but behavior also continuously influences testosterone. This feedback loop is not a minor footnote. It is the central organizing principle of hormonal behavioral science, and understanding it changes everything about how you should think about your own hormonal health.

Dr. Robert Sapolsky, the Stanford neuroendocrinologist whose 30-year research career has focused on the biology of stress, behavior, and social hierarchy — documented brilliantly in his books “Why Zebras Don’t Get Ulcers” and “Behave” — has argued forcefully and repeatedly against hormonal determinism. Sapolsky’s core point: testosterone does not create behavior. It modulates the probability of behavior that is already in the repertoire. It lowers the threshold for behaviors that are already possible given the individual’s history, learning, and social context. A hormone cannot install a program that was never there.

This distinction sounds subtle. It has enormous practical implications. Let us follow them.


Part Two: The Aggression Myth — Dismantling the Most Persistent Lie in Male Biology

No aspect of testosterone mythology is more entrenched than the aggression link. It pervades sports commentary, courtroom defenses, evolutionary psychology pop writing, and dinner table conversations. Men with high testosterone are assumed to be volatile, dangerous, prone to violence. The science tells a far more complicated and far more interesting story.

Let us start with what the data actually shows. A rigorous 2016 meta-analysis by Dr. Justin Carré at Nipissing University and Dr. Neil Olmstead examined the accumulated research on testosterone and human aggression. When they pooled the data across studies, the correlation between baseline testosterone levels and aggressive behavior was approximately 0.14. In research terms, this is a small effect — it means that testosterone level explains roughly 2% of the variance in aggressive behavior. You cannot predict whether a man will be aggressive from his testosterone level. The hormone is simply not doing what the mythology claims it is doing.

What does predict aggression? The factors that consistently emerge in the behavioral science literature are: prior history of aggressive behavior (the strongest predictor), social context and perceived provocation, alcohol consumption, acute stress and threat to status or resources, early childhood adversity, and specific personality traits like trait anger and low self-control. Testosterone is nowhere near the top of the list.

But the story gets more detailed and more interesting than simply debunking the myth. Research suggests that testosterone may interact with certain social contexts to increase aggressive responding in specific ways. Work by Dr. Pranjal Mehta at the University of Oregon introduced the concept of the dual-hormone hypothesis: the relationship between testosterone and dominant or aggressive behavior depends on cortisol levels. When cortisol is low — meaning the individual is not under acute stress — higher testosterone is associated with approach-oriented, status-seeking behavior. When cortisol is high, testosterone shows no consistent relationship to aggressive behavior, or may even suppress it. The stress system gates the testosterone system.

This is critical for understanding real-world aggression. Most violent incidents occur in contexts of high stress, perceived threat, alcohol intoxication, and status challenge — contexts where cortisol is elevated and the dual-hormone model predicts no simple testosterone-aggression link. The men who perpetrate most violence do not necessarily have high testosterone. They have histories of trauma, attachment disruption, poor impulse control, substance use, and social circumstances that generate constant status threat. Blaming their testosterone is scientifically wrong and morally evasive.

Christoph Eisenegger’s 2010 Nature study — which I mentioned in the opening — deserves expanded discussion because it is one of the most illuminating pieces of research in this space. Eisenegger and colleagues gave testosterone or placebo to women in a double-blind design and observed behavior in an ultimatum game where participants could make financial offers that others could accept or reject. The expectation, based on testosterone mythology, was that testosterone would cause more aggressive, less fair offers.

The actual finding was this: women who received testosterone made higher, fairer offers than the placebo group. But — and this is the stunning part — women who received placebo but believed they had received testosterone made lower, less fair offers than everyone else. The expectation of testosterone effects was more behaviorally powerful than the hormone itself. Testosterone mythology is partly self-fulfilling. When people believe they are hormonally primed for dominance and selfishness, they act accordingly — and the hormone itself has nothing to do with it.

Eisenegger offered an elegant interpretation of this result: testosterone may actually promote status-seeking through prosocial channels — through generosity, fair dealing, and reputation building — rather than through aggressive dominance. In social species where long-term status depends on cooperation and reciprocity, a hormone that increases generous behavior makes more evolutionary sense than one that triggers random aggression. The mythology had the story backwards.

Consider a case study that brings this to life. Thomas is a 36-year-old former Marine who spent two tours in Afghanistan before transitioning to civilian life as a construction project manager. His wife had suggested he get his testosterone checked, having absorbed the cultural narrative that his aggression might be hormonal.

His testosterone came back at 680 ng/dL — solidly in the upper half of the normal range, but nothing remarkable. His cortisol profile, however, was severely dysregulated — high throughout the day rather than following the normal morning peak and afternoon decline. When we worked through his history, the picture was clear: Thomas had spent years in a hyper-vigilant operational state that had never been fully deactivated. His nervous system was still scanning for threat in every social interaction. The “aggression” was not testosterone-driven. It was a dysregulated stress response in a man whose threat detection system had been trained to stay on high alert.

The intervention was not hormonal. It was behavioral and physiological — a systematic approach to stress regulation, sleep optimization, and what Dr. Peter Levine calls somatic processing of trauma. Within four months, Thomas’s outbursts had essentially stopped. His cortisol profile had normalized. His testosterone, if anything, rose slightly. The hormone was never the problem. The mythology almost caused us to treat the wrong thing entirely.


Part Three: The Challenge Hypothesis — Testosterone, Competition, and the Experience of Winning

If testosterone’s relationship to aggression is weak and context-dependent, what is its most strong behavioral association? The answer, supported by several decades of converging research, is status-seeking behavior and the competitive drive — specifically, the dynamic relationship between competitive experience and hormonal state that researchers call the Challenge Hypothesis.

The Challenge Hypothesis was originally formulated by behavioral ecologist John Wingfield and colleagues in 1990 in their study of avian behavior. The core proposition: in species where males compete for reproductive access, testosterone rises in anticipation of and during competitive challenge, remains elevated in winners, and declines in losers. This pattern serves an adaptive function — it primes winners with the hormonal state that supports continued competition and status maintenance, while signaling losers to disengage from further costly confrontation.

Dr. Allan Mazur at Syracuse University and Dr. Michael Booth pioneered the application of the Challenge Hypothesis to human behavior. In a series of landmark studies in the 1990s, Mazur and Booth documented testosterone fluctuations in male athletes before and after competition. Tennis players showed elevated testosterone before matches and further elevation after wins; testosterone declined after losses. The pattern held across different sports and different competitive formats.

But Mazur’s most important contribution was showing how broadly the Challenge Hypothesis applies beyond physical competition. He found the same pattern in chess players — a purely cognitive competition with no physical component. Medical students showed testosterone elevations after passing boards and declines after failing. Law school graduates taking bar exams showed similar patterns. Even watching your sports team win or lose generates testosterone fluctuations in fans that mirror the pattern in the athletes themselves. The competitive experience, not the physical exertion, drives the hormonal response.

Research by Dr. Paul Bernhardt and colleagues published in the journal Physiology and Behavior in 1998 provided a particularly striking demonstration of this vicarious competition effect. The study examined testosterone in fans of the 1994 World Cup soccer final between Brazil and Italy and the 1994 NBA finals between Houston and New York. Fans of the winning team showed significant testosterone elevations after the game; fans of the losing team showed declines. These men did nothing physically. They watched other people compete. And their hormonal systems responded as if they themselves had won or lost.

What does this tell us? It tells us that testosterone is deeply tied to the psychological experience of status, competence, and mastery — not to the physical mechanics of competition or the biological reality of physical confrontation. When you feel like a winner, when you experience yourself as competent and successful in contexts that matter to you, your testosterone rises. When you feel like you are losing — professionally, socially, personally — your testosterone falls.

This has profound practical implications that most hormonal health conversations completely miss. The question is not just “what is my testosterone level?” The question is “what is the competitive and mastery landscape of my life?” A man who has abandoned meaningful challenge, who has settled into comfortable but unchallenging routines, who no longer has goals that test him, will experience hormonal consequences — not because of some external deficiency, but because the behavioral context that drives testosterone is absent.

I want to spend some time on Marcus, a case I referenced briefly in the introduction. Marcus is 44 years old, a sales executive at a mid-sized technology company, married with two children, by most external measures successful. He came to me reporting what he described as a pervasive flatness — not clinical depression, but a loss of edge, of drive, of the feeling that what he was doing mattered. His mornings were grey. His work felt mechanical. He was going through the motions of a life that should have felt good but did not.

His physician had run a comprehensive metabolic panel including testosterone at Marcus’s request. Total testosterone came back at 412 ng/dL. The physician noted this was low-normal and suggested a referral to a hormone specialist. Marcus, to his credit, had enough intuition to wonder if the problem was not hormonal in origin. He came to me instead.

The picture that emerged over several weeks of coaching was this: Marcus had last taken on a genuine professional challenge three years prior, when he had led a difficult product launch that required everything he had. The launch had succeeded, and in its wake, he had been promoted to a management role that was comfortable but essentially administrative. He was good at it. He was not stretched by it. His role required competence, not growth. The thrill of genuine challenge — the hormonal and psychological fuel that had driven him for the first fifteen years of his career — had been replaced by the comfort of competence.

His marriage was similarly settled — not troubled, but routine. His recreational life was essentially absent; he had stopped competing in the amateur cycling events that had given him a competitive outlet through his thirties because it felt indulgent given family demands.

We rebuilt his competitive context over six months. He negotiated a lateral move to lead a division that had been struggling — genuinely difficult, politically complex, with real risk of failure. He returned to competitive cycling, entering three events over the following season. He set a specific financial and impact goal with a clear twelve-month timeline.

At six months, Marcus retested his testosterone: 624 ng/dL. He had not changed his diet significantly. He had not started testosterone therapy. He had not added supplements beyond vitamin D for a pre-existing deficiency. What changed was his life context. The hormone followed the experience of challenge, mastery, and meaningful competition. Same man. Radically different hormonal output.

I want to be careful here not to oversimplify. Marcus’s case was relatively clean — a man whose hormonal depression was primarily contextual, without underlying medical issues. Not every case of low testosterone responds to lifestyle reengagement. Some men have genuine pathological hypogonadism that requires medical treatment. But the number of men who are sent to testosterone specialists before anyone asks them “are you living in a way that generates regular experiences of competence and challenge?” is a genuine failure of the system.


Part Four: Testosterone, Fatherhood, and the Bonding Paradox

Episode 326 One of the most counterintuitive and, I think, most important bodies of research in all of hormonal behavioral science concerns the relationship between testosterone, fatherhood, and pair bonding. The popular narrative about high-testosterone men presents them as lone wolves — dominant, independent, commitment-averse, sexually driven toward novelty. The data presents a much more sophisticated portrait of a hormonal system that is exquisitely adaptive to social role.

The foundational research here comes from Dr. Lee Gettler at the University of Notre Dame, whose work on testosterone and paternal behavior has transformed how we understand hormonal flexibility in men. In a landmark 2011 study published in the Proceedings of the National Academy of Sciences, Gettler and colleagues followed 624 Filipino men from young adulthood through the transition to fatherhood. The study measured testosterone at baseline and again several years later, comparing men who had become fathers with those who had not.

The findings were striking. Men who became fathers showed significantly larger testosterone declines than childless men over the study period. But the truly remarkable finding was the dose-response relationship with caregiving involvement: fathers who reported the highest levels of hands-on caregiving — nighttime care, feeding, playing, bathing — showed the largest testosterone declines of all. The more actively involved a man was in caring for his child, the lower his testosterone fell.

In a culture saturated with testosterone mythology, this finding is almost universally misread. Men hear “fatherhood lowers testosterone” and interpret it as evidence that fatherhood diminishes men — that it costs them something essential and masculine. This interpretation is exactly backwards.

What Gettler’s research actually demonstrates is that the male endocrine system is not fixed and unchanging — it is socially sensitive, context-responsive, and adaptive. When a man’s primary social role shifts from mate-seeking and status competition to child caregiving, his hormonal system adapts to support the demands of that role. Lower testosterone in actively caregiving fathers correlates with better paternal responsiveness to infant cues, more emotionally attuned parenting, and — in subsequent research by Gettler and colleagues — better developmental outcomes in the children. The biology is doing exactly what it should do.

Dr. Gettler has also shown that this effect is reversible. When caregiving demands decrease as children age, testosterone levels recover. The endocrine system is flexibly tracking the demands of the social environment, not permanently altered by fatherhood. This is not hormonal damage. This is hormonal sophistication.

Dr. Christopher Kuzawa at Northwestern University, who collaborated with Gettler on much of this work, has extended the analysis to evolutionary context. In mammalian species generally, intensive paternal care is associated with lower testosterone — the endocrine systems of caring fathers across species show convergent adaptations. Human males are among the most extensively paternal of all primates. Our capacity for testosterone reduction in caregiving contexts is part of what enables us to form the kind of stable, invested family units that have been central to human reproductive success across evolutionary history.

The pair bonding research tells a complementary story. Research by Dr. Sari van Anders and colleagues at the University of Michigan using an approach she calls “Steroid/Peptide Theory of Social Bonds” has systematically examined how relationship context shapes testosterone. Van Anders’s work shows that men in committed, sexually satisfying relationships tend to have lower testosterone than single men in the competitive dating market. But the direction of this effect depends on what aspect of the relationship is salient: intimate, nurturing contact (holding a partner, sexual intimacy with emotional connection) tends to lower testosterone, while sexual desire and arousal activate testosterone systems.

What this means practically is that testosterone in a man’s relational context is not a fixed trait — it is a dynamic signal tracking where he is in the bonding-competition spectrum of his social life. A man who is actively competing for mates will have a different hormonal profile than the same man six months into a deeply satisfying relationship. Neither profile is pathological. Each is appropriate to its context.

The clinical relevance of this is significant. I have worked with multiple men who sought hormonal evaluation because they noticed testosterone-like symptoms (lower libido, reduced drive) after entering long-term relationships. In some cases, their levels had genuinely declined. In most cases, the relationship itself was generating the change — the hormonal system was reflecting the shift from mate-seeking to pair-bonding. Treating this as a pathological deficiency to be corrected with exogenous testosterone would be both scientifically unfounded and potentially relationship-disruptive.

Consider Daniel, 38, a corporate attorney who had been through three relationships in five years. In our first conversations, he described a pattern: intense initial attraction, a period of genuine happiness, followed by what he called “the fade” — diminishing desire, increasing irritability, a sense that the relationship was constraining him. He had tested his testosterone on two occasions, both returning high-normal results around 720-750 ng/dL. He had begun to construct a narrative in which his hormonal profile made committed monogamy incompatible with his nature.

This is a story I have heard versions of many times. The hormonal narrative serves a defensive function — it biologizes a behavioral pattern and places it outside the reach of responsibility or change. The pattern was real. Daniel did experience the fade. But the fade was not testosterone-driven in the sense of being biologically inevitable. It was the predictable output of a man who had never learned to build and sustain intimacy past the initial novelty phase, who had been raised in a family where emotional depth was unavailable, and whose relationships had consistently followed the same arc because he had never developed the skills to navigate the transition from romantic excitement to sustained connection.

His testosterone was not the problem. The testosterone narrative was part of the problem — it was providing a biologically respectable exit from the work of grown-up relational development. We spent eight months working on attachment patterns, emotional avoidance, and the specific skills of building depth in a relationship he was genuinely trying to sustain. The “fade” he had accepted as hormonal inevitability turned out to be a learnable, changeable pattern. Hormones follow context. Context can be changed.


Part Five: The Low Testosterone Crisis — Real Science, Real Problems, and Real Industry Distortion

Now let us engage with what has become one of the dominant health narratives for men in the early 21st century: the claim that testosterone levels have been declining for decades, that men are in the grip of a hormonal crisis, and that this crisis explains a broad range of male problems from reduced vitality to behavioral changes at the population level. There is genuine science here. There is also significant distortion, and it matters which is which.

The foundational study in this literature is a 2007 analysis by Dr. Thomas Travison and colleagues published in the Journal of Clinical Endocrinology and Metabolism. Travison used data from the Massachusetts Male Aging Study to compare testosterone levels in men of the same age across different time cohorts, attempting to isolate secular trends from aging effects. His finding: average testosterone levels in American men appear to have declined by approximately 1% per year from the late 1980s through the early 2000s, independent of the effects of aging. A 60-year-old man in 2004 had testosterone roughly 17% lower than a 60-year-old man in 1987, after controlling for age and health factors.

Subsequent studies from Denmark and other countries have produced broadly consistent findings, suggesting this is not an American phenomenon but a trend in multiple developed nations. The magnitude of the decline and its drivers remain debated, but the basic finding has enough replication to take seriously.

What is causing it? Here the research points in several directions, none of them mysterious. Obesity rates have risen dramatically over the same period, and adipose tissue — particularly visceral abdominal fat — expresses the enzyme aromatase, which converts testosterone to estradiol. As average body fat has risen, average testosterone has declined through this mechanism. Physical activity has declined. Sleep quality and duration have declined. Chronic psychosocial stress — documented across measures from work demands to financial insecurity to social isolation — has increased. Environmental exposure to endocrine-disrupting chemicals (EDCs) found in plastics, food packaging, pesticides, and industrial chemicals has increased substantially.

These are not obscure factors. They are the defining features of modern sedentary, stressed, sleep-deprived, chemically contaminated life. And they are, at least partially, modifiable.

The EDC issue deserves particular attention because it is both robustly supported and widely underappreciated. Dr. Shanna Swan at Mount Sinai Medical Center has spent her career documenting the effects of phthalates and other endocrine disruptors on male reproductive health. Her research shows that phthalate exposure in utero is associated with reduced anogenital distance in male infants — a proxy for prenatal testosterone exposure — and with reduced sperm counts and testosterone levels in adult men. Swan’s work, summarized in her book “Count Down,” argues that we are in the midst of a genuine reproductive health crisis driven substantially by chemical exposure. This is not fringe science. It is peer-reviewed, replicated, and increasingly the scientific consensus.

Now here is where I need to introduce the complication that makes this topic so difficult to navigate clearly: the testosterone replacement therapy industry has a staggering financial interest in framing any male health concern as a testosterone deficiency requiring pharmaceutical intervention. The global TRT market exceeded $5 billion annually by 2020 and was growing at approximately 7% per year. Direct-to-consumer testosterone clinics have proliferated across the United States, many operating on business models that involve minimal diagnostic rigor and extremely rapid prescription.

Dr. Abraham Morgentaler at Harvard Medical School is one of the few voices who can credibly navigate both sides of this debate. Morgentaler spent decades fighting the over-cautious medical establishment that refused to prescribe TRT for clearly deficient men based on a discredited hypothesis linking testosterone to prostate cancer (he helped demonstrate this link was wrong). He is a genuine advocate for appropriate testosterone treatment. He is also a vocal critic of the current over-prescription landscape, arguing that many men are being prescribed TRT without adequate diagnosis, without lifestyle optimization, and without the long-term monitoring that responsible treatment requires.

Morgentaler has articulated what I consider the right framework: genuine hypogonadism — consistently low testosterone with clinical symptoms — is a real medical condition that benefits from treatment. The challenge is that the threshold for “genuine hypogonadism” has been gradually lowered by the combined influence of pharmaceutical marketing, patient demand, and clinicians who find it easier to write a prescription than to investigate root causes. A man with a testosterone of 380 ng/dL who is obese, sleeps five hours a night, is chronically stressed, and does not exercise is not the same clinical patient as a man with the same number who eats well, sleeps eight hours, trains regularly, and manages stress effectively. The first man needs lifestyle intervention. The second may need medical investigation. Treating both identically with TRT is not good medicine.


Part Six: Testosterone Across the Lifespan — What to Expect and How to Navigate It

Testosterone levels in men follow a predictable arc across the lifespan, and understanding this arc is important for contextualizing your own numbers at any given age.

The prenatal testosterone surge shapes the developing male brain and body in ways that persist throughout life. The pubertal surge — beginning typically between 9 and 14 years of age — is the hormonal event most people associate with male development, driving the physical changes of adolescence as well as the emergence of sexual desire, competitive drive, and the increased status-seeking that characterizes adolescent male behavior. Peak testosterone levels are reached in late adolescence and early adulthood, typically between ages 19 and 25.

From roughly age 30 onward, testosterone declines at approximately 1-2% per year on average. This is a normal, expected, biological process — not a disease. By age 70, most men have testosterone levels roughly 35% lower than their peak. This decline is associated with gradual changes in muscle mass, bone density, energy levels, sexual function, and mood — but these changes occur on a slow trajectory and are often substantially influenced by the lifestyle factors discussed above.

The concept of “late-onset hypogonadism” — clinically significant testosterone deficiency in aging men with accompanying symptoms — is genuinely real, but it represents a subset of aging men, not a universal condition. Research from the European Male Aging Study, a large longitudinal study of men aged 40-79, found that only about 2% of men aged 40-79 had a syndrome of low testosterone with symptomatic sexual, physical, and psychological consequences — what the researchers defined as late-onset hypogonadism. Compare that to the proportion of men in that age range who are currently receiving testosterone prescriptions, and you see the extent of the disconnect between clinical reality and current practice.

The most important practical point for men in their 30s, 40s, and 50s: the rate of testosterone decline is substantially modifiable through lifestyle. Longitudinal research shows that men who maintain healthy weight, exercise regularly, sleep adequately, and manage stress well can sustain testosterone levels into later middle age that match those of younger sedentary men. You cannot stop the clock entirely. You can substantially influence how fast it runs.

For men who are navigating midlife transitions — career plateaus, relationship changes, physical changes, the famous midlife reckoning — understanding the hormonal landscape is part of but not the whole of the story. I explore this in depth in our episode on reinvention after 50, where the hormonal dimension intersects with identity, purpose, and meaning in ways that cannot be reduced to a lab value.


Part Seven: The Hormonal Literacy Protocol — A Framework for Intelligent Self-Understanding

Part Seven: The Hormonal Literacy Protocol We have covered a great deal of ground. Now I want to give you a systematic framework for applying what the research shows to your own life. I call this the Hormonal Literacy Protocol, and it has four levels of progressive depth.

Level One: Measure Intelligently

The first step in hormonal literacy is getting useful data. This sounds obvious, but the majority of men who get their testosterone tested receive inadequate information and draw incorrect conclusions from it.

What to test: Total testosterone alone is insufficient. A meaningful panel includes total testosterone, free testosterone or calculated free testosterone (using SHBG and albumin), SHBG, LH, FSH, estradiol (estrogen), prolactin (elevated prolactin suppresses testosterone and should be investigated), cortisol (ideally a diurnal profile), DHEA-S, complete blood count (especially hematocrit), PSA if over 40, and a metabolic panel including fasting glucose and lipids.

When to test: Always in the morning, ideally between 7 and 10 AM, on two separate occasions at least a week apart. A single measurement has too much within-individual variability to be diagnostic. Make sure you have slept normally before testing — a single night of poor sleep can lower testosterone by 10-15%. Test when you have not had an unusually intense training session in the previous 24 hours, which can temporarily alter levels.

How to interpret your number: Context your result. A testosterone of 450 ng/dL in a 60-year-old man with good energy, strong libido, adequate muscle mass, and stable mood is probably fine. The same number in a 32-year-old man with significant fatigue, low libido, loss of morning erections, depression, and difficulty building muscle despite appropriate training deserves investigation. Symptoms matter as much as numbers. The research consistently shows that testosterone-associated symptoms are a better guide to treatment decisions than absolute levels alone.

Level Two: Audit and Optimize Lifestyle Inputs Before Anything Else

Before any discussion of hormonal intervention, you must conduct a rigorous, honest audit of the lifestyle factors that most powerfully determine your testosterone environment. This is not optional preliminary work. For a large proportion of men, it is the complete solution.

  1. Sleep: Dr. Rachel Leproult and Eve Van Cauter’s University of Chicago research showed that restricting sleep to five hours per night for one week in healthy young men reduced daytime testosterone levels by 10-15%. That magnitude of suppression is comparable to what testosterone declines by across 10-15 years of aging. Sleep is the most powerful natural testosterone optimizer available. If you are sleeping less than seven hours regularly, everything else is secondary. Prioritize sleep architecture: regular sleep/wake times, dark room, cool temperature, no screens in the final hour. If you have sleep apnea — extremely common in men with low testosterone, and both condition and cause — treating it meaningfully raises testosterone.
  2. Resistance training: Heavy compound movements — squats, deadlifts, barbell presses, rows — produce acute testosterone elevations and support long-term hormonal health through multiple mechanisms including reduced body fat, improved insulin sensitivity, and direct HPG axis stimulation. A well-designed resistance training program lifting at 70-85% of maximum effort, three to five days per week, is among the most evidence-based lifestyle interventions for testosterone support. Volume matters; occasionally training past the point of recovery capacity can suppress the system.
  3. Body composition: Visceral adiposity — fat around the abdominal organs — is one of the strongest lifestyle predictors of testosterone suppression. The aromatase enzyme in adipose tissue converts testosterone to estradiol, and the inflammatory state of metabolic dysfunction further disrupts the HPG axis. Even modest weight loss of 5-10% of body weight in overweight or obese men produces clinically significant testosterone increases. Body composition improvement is hormonal intervention.
  4. Stress regulation: Chronic psychological stress activates the HPA axis, driving cortisol elevation that competes with testosterone at the cellular level and suppresses GnRH release from the hypothalamus. This is not a minor effect. Men in chronically high-stress life situations — demanding jobs, troubled relationships, financial crisis, caregiving burden without support — will tend toward lower testosterone independent of all other factors. The path forward is not to eliminate challenge (which is good for testosterone) but to build stress resilience and recovery capacity. The Resilient Wisdom framework for stress navigation covered in our stress resilience episode is directly relevant here.
  5. Reduce endocrine disruptor exposure: Use glass or stainless steel food and beverage containers instead of plastic. Filter your drinking water. Eat organic produce when budget allows, particularly for the Environmental Working Group’s “Dirty Dozen” high-pesticide crops. Avoid heating food in plastic containers. Choose personal care products without phthalates and parabens. These steps are individually modest but cumulatively meaningful for a system that is sensitive to small chemical signals.
  6. Nutritional adequacy: Zinc deficiency is associated with testosterone suppression — oysters, red meat, pumpkin seeds, and chickpeas are good dietary sources. Vitamin D deficiency (extraordinarily common in northern latitudes and indoor-dwelling populations) is independently associated with lower testosterone — supplementation in deficient men consistently produces modest testosterone improvements. Adequate dietary fat from whole food sources is necessary for steroid hormone synthesis. Highly processed diets are associated with worse hormonal profiles through multiple mechanisms.

Level Three: Engineer the Behavioral Context That Drives Testosterone

Episode 326 This is the level that virtually no hormonal health program addresses — and it may be the most important. Based on the Challenge Hypothesis research, the fatherhood studies, the pair bonding literature, and the bidirectional nature of the testosterone-behavior relationship, your behavioral context is continuously and significantly shaping your hormonal environment. You need to audit this systematically.

Ask yourself the following questions with genuine honesty:

Does my daily life generate regular, meaningful experiences of competence and mastery? Or am I in routines that are comfortable but no longer challenging? Have I abandoned goals that genuinely stretch me because of fear of failure, time pressures, or the comfort of not risking losing? Am I in a social and professional context where I experience myself as capable and growing? Or am I in environments where I feel consistently diminished, unrecognized, or stagnant?

Are my relationships characterized by genuine depth, mutual respect, and satisfaction? Or are they sources of chronic conflict, unmet needs, and emotional frustration? Have I allowed the pattern-work of relationship — the hard, gradual deepening that requires skill and willingness — or have I been choosing comfort and avoidance?

Am I living in a way that regularly activates my sense of purpose and significance? Or have I lost connection to why what I do matters?

These are not soft questions. They are questions about the behavioral inputs to a biological system. A man who honestly answers them and finds significant deficits has found the primary target for intervention — not a hormone clinic.

For the discipline and behavioral architecture that creates the conditions for mastery-driven hormonal health, our episode on discipline systems provides detailed frameworks. For the relational dimension, our episode on calibrated reunion and relationship rebuilding addresses how to create the kind of relational depth that supports rather than suppresses male vitality.

Level Four: Engage Medical Expertise Appropriately and Intelligently

Level Four: Engage Medical Expertise Appropriately and Intelligently If you have conducted a rigorous three-to-six month audit and optimization of Levels One through Three and still have persistent, clinically significant symptoms of testosterone deficiency — genuine fatigue that does not respond to sleep improvement, low libido unrelated to relationship or psychological factors, loss of morning erections, significant loss of muscle mass and strength despite appropriate training, clinical depression — then a conversation with a knowledgeable endocrinologist or urologist is appropriate and warranted.

How to engage productively: Bring your data. Bring two morning testosterone panels with full hormonal context. Bring your lifestyle audit — sleep, exercise, body composition, stress history, diet. Come with questions. Ask about the full diagnostic picture, not just total testosterone. Ask about LH and FSH levels, which tell you whether low testosterone is originating in the testes (primary hypogonadism, often requiring TRT) or in the brain-pituitary axis (secondary hypogonadism, which has different treatment implications and more lifestyle-responsive etiologies).

Be skeptical of any clinician who prescribes TRT at the first visit without exploring lifestyle factors and without ruling out secondary causes. Be equally skeptical of any clinician who dismisses your symptoms as inevitable aging without thorough investigation. You deserve individualized, evidence-based assessment — and increasingly, you need to advocate for it because the incentive structures of both conventional medicine (time-pressed, protocol-driven) and direct-to-consumer hormone clinics (revenue-driven) do not reliably produce it by default.

If TRT is ultimately indicated: understand that it is a long-term commitment with ongoing monitoring requirements. TRT suppresses endogenous testosterone production through HPG axis feedback, meaning stopping it abruptly after a period of use will result in a period of very low testosterone while the natural system restarts. If fertility is a current or future consideration, discuss this specifically — TRT typically suppresses sperm production, and alternatives like clomiphene (which stimulates the natural system) may be more appropriate for men who want to preserve fertility. Monitor hematocrit, PSA, and cardiovascular biomarkers on the schedule your clinician recommends.


Part Eight: The Deeper Meaning — What Testosterone Tells Us About the State of Men

The obsession with testosterone in contemporary male culture is not primarily a health story. It is a meaning story. When men are confused about who they are and what they are for — when they lack direction, meaningful challenge, genuine purpose, and deep relationships — they reach for biological explanations. The hormone becomes the answer to questions that are actually about identity, agency, and significance.

There is a man reading this who has been told — or has told himself — that the difficulty he is having feeling like himself is hormonal. Maybe it is, in part. But I want to suggest, based on many years of working with men in exactly this place, that the most important question is not “what is my testosterone level?” It is: “Am I living in a way that generates the experiences of competence, challenge, connection, and purpose that make me feel alive?”

The biology is downstream of the life you are living. This is one of the most liberating findings in all of behavioral endocrinology, and it is almost never communicated this way. Your hormonal profile is not a fixed trait you were dealt and must manage. It is a continuous output of how you are living — what you are pursuing, what risks you are taking, how you are relating, whether you are sleeping and moving and eating in ways that support your biology, whether you are embedded in relationships and communities where you matter and contribute.

Change those inputs, and you change the output. Not always completely. Not always immediately. But in most cases, more substantially than any pharmaceutical intervention produces in someone who has not addressed root causes.

The man who achieves genuine hormonal literacy — who understands what his body’s signals are telling him about his life context, who can read the relationship between how he is living and how he is feeling without either catastrophizing into victim narratives or dismissing real biological factors — is operating at a level of self-knowledge that most men never reach. That is the actual goal. Not a number. Not a clinic. Understanding in service of a better life.

For the broader identity framework within which hormonal health lives, I encourage you to listen to our episode on what authentic strength actually means. And for the purpose dimension — the sense of direction and significance that most powerfully shapes the behavioral context driving hormonal health — the episode on purpose through service offers a framework that complements everything we covered today.

“Testosterone doesn’t make the man. The man makes the context that shapes the testosterone. Your hormones are a mirror, not a master. Read the mirror honestly, then change what it is reflecting.” — Vladislav Davidzon


Episode 326: Your Questions Answered

  1. Is there an optimal testosterone level I should target? There is no universally optimal number because individuals vary enormously in androgen receptor density and sensitivity, SHBG levels, and the free-testosterone fraction that actually drives biological effects. Clinical deficiency is defined as total testosterone consistently below 300 ng/dL combined with symptomatic evidence — but many men feel and function optimally at levels well above the clinical lower threshold. Rather than chasing a number, track your own baseline over time and pay attention to how you feel, perform, and relate at different levels. Symptom patterns are more clinically meaningful than absolute values for most men.
  2. Does competitive sports fandom actually affect testosterone levels? Yes, and the research is strong on this point. Studies going back to the 1990s have documented testosterone fluctuations in sports fans that mirror the pattern in athletes — elevations after their team wins, declines after losses — across soccer, basketball, baseball, and other sports. The effect is real but modest in absolute magnitude, and it does not meaningfully affect health outcomes. What the finding tells us conceptually is more important: the testosterone system responds to vicarious experience of winning and losing, which speaks to its deep roots in social identity and group competition rather than individual physical performance.
  3. Should I be concerned about testosterone if I am not experiencing obvious symptoms? No. Absent symptoms — genuine fatigue, low libido, loss of muscle despite training, mood disruption, cognitive fog — testing testosterone as a routine screening test in healthy men without risk factors is of limited clinical utility. The American Urological Association and Endocrine Society do not recommend screening testosterone in asymptomatic men. If you are curious about your baseline for tracking purposes, that is reasonable, but treat it as information rather than a mandate for intervention.
  4. Can psychological trauma lower testosterone? Yes, through multiple mechanisms. Post-traumatic stress involves chronic HPA axis dysregulation with elevated cortisol, which directly suppresses testosterone production. Additionally, the social withdrawal, depression, and reduced physical activity associated with untreated trauma all contribute to hormonal suppression. Research on combat veterans with PTSD consistently documents lower testosterone relative to non-PTSD controls. Trauma treatment — not just hormonal intervention — is the appropriate primary approach for this presentation.
  5. If I start testosterone therapy, is it a lifelong commitment? Not necessarily, but it is a significant commitment. TRT suppresses endogenous production through HPG axis feedback. Stopping after an extended period will result in a recovery phase of potentially several months before natural production normalizes. For men who develop secondary hypogonadism (originating in HPG axis dysfunction rather than testicular failure), alternative treatments like clomiphene citrate or human chorionic gonadotropin (hCG) can stimulate natural production and are reversible options worth discussing with a knowledgeable clinician before committing to exogenous testosterone.

Part Nine: Practical Applications — Building Your Hormonal Health Architecture

Let me bring all of this research together into the specific, actionable daily practices that the evidence most strongly supports. I want to be concrete here because the gap between scientific understanding and practical implementation is where most people get lost.

The morning anchoring practice: Your testosterone peaks in the early morning hours. Use this window strategically. Exposure to natural light within thirty minutes of waking helps regulate circadian rhythms that influence cortisol and testosterone cycling. Brief intense physical activity in the morning — even ten minutes of bodyweight exercises — activates the nervous system and creates a small competitive hormonal stimulus. Cold exposure, whether through a cold shower or cold plunge, activates the sympathetic nervous system and has been associated in small studies with modest testosterone-supporting effects, though the primary benefit is likely mood and alertness through catecholamine release. These practices do not transform your hormonal landscape individually. Together, as anchors for a morning that sets a tone of competence and agency, they create cumulative behavioral feedback to the endocrine system.

Training structure for hormonal health: The research on exercise and testosterone is more detailed than most gym culture acknowledges. Acute testosterone elevation from training is real but transient — it returns to baseline within an hour or two post-workout. The long-term hormonal benefit of training comes through body composition improvement, insulin sensitivity, and the behavioral feedback of regular challenge and competence that we have discussed. For maximizing these effects: prioritize compound movements at moderate to high intensity. Include adequate recovery — training more than five days per week without periodization often suppresses the system through overreaching. Track progressive overload — the experience of actually getting stronger over time provides the mastery experience that drives Challenge Hypothesis hormonal responses. Chronic high-volume endurance training (training for ultramarathons, high-volume triathlon preparation) can suppress the HPG axis and is a known cause of exercise-induced hypogonadism — relevant for men who pursue these sports seriously.

Sleep optimization as hormonal intervention: Given that sleep restriction is among the most powerful suppressors of testosterone — with even one week of short sleep producing effects equivalent to a decade of aging — sleep deserves detailed attention. The practical priorities: consistent sleep schedule seven days a week (social jet lag — shifting sleep times drastically on weekends — disrupts diurnal hormone rhythms as damaging as shift work in some research). Room temperature of 65-68 degrees Fahrenheit supports the body temperature drop associated with sleep onset and deep sleep architecture. Complete darkness — even small amounts of light exposure during sleep impair melatonin and shift the cortisol-testosterone relationship. Addressing obstructive sleep apnea, which is dramatically underdiagnosed in men with low testosterone (it is both a consequence of low testosterone through reduced upper airway muscle tone and a cause through the cortisol response to hypoxic events), can produce testosterone improvements of 15-25% in some studies.

Social and competitive architecture: Building the behavioral context that drives Challenge Hypothesis testosterone responses requires deliberate attention to competitive engagement. This does not mean manufactured competition for competition’s sake. It means identifying the domains of genuine challenge where you want to develop and win — and building specific, measurable goals with deadlines that create real stakes. Whether this is professional performance, athletic competition, creative achievement, or financial objectives, the system needs targets with consequences. Men who have abandoned all domains of genuine challenge — through comfort, through fear of failure, through the busyness excuse — are depriving their endocrine systems of the hormonal fuel of mastery. Rebuilding that context is not optional supplementation. It is the primary intervention.

Managing the chemical environment: While individual exposure-reduction steps are modest in effect, the cumulative burden of endocrine disruptor exposure is real and worth systematic attention. The highest-use changes: replace plastic water bottles with stainless steel or glass. Use glass containers for food storage, especially for anything acidic or fatty (these leach plasticizers most readily). Filter your tap water — a basic activated carbon filter removes significant chlorine and many pesticide residues. Choose personal care products from brands that explicitly avoid parabens and phthalates. These steps require upfront attention but become automatic habits quickly. Their hormonal benefit is real but measured — do not expect transformative effects from chemical reduction alone. Expect a modest but genuine reduction in an ongoing suppressive burden.

The purpose and meaning dimension: This is the last and in some ways the most powerful element of the Hormonal Literacy Protocol. Research on testosterone and purpose has been limited by the difficulty of measuring purpose quantitatively, but the connections are increasingly supported. Studies linking occupational meaning with testosterone, the Challenge Hypothesis research showing mastery experiences drive hormonal state, and the fatherhood research showing that role clarity and investment in a meaningful caregiving role produces appropriate hormonal adaptation all point in the same direction: living with clear purpose in domains that genuinely matter to you creates the behavioral context that most powerfully supports long-term hormonal health.

The man who knows why he is getting up in the morning — who has goals that pull him forward, relationships that require his best, and a sense of contribution that makes his work meaningful — is not going to be reading this wondering why he feels flat. The hormones will not be the problem. This is not motivational content. It is endocrine biology. Purpose drives challenge. Challenge drives mastery experiences. Mastery drives testosterone. The chain is real.

We have built an entire episode around the purpose dimension — our conversation on purpose through service goes deep into how orienting your life around meaningful contribution creates the conditions for hormonal and psychological vitality. And our episode exploring how high performers navigate anxiety addresses the darker side of the drive state — what happens when the competitive context becomes a source of chronic threat rather than challenge.

You have the framework now. Measure intelligently. Optimize lifestyle inputs rigorously before seeking intervention. Engineer the behavioral context that drives testosterone through challenge, mastery, and meaningful relationship. And if, after all of that, genuine clinical deficiency persists, engage medical expertise with the sophistication this complex system deserves.

Your hormones are a mirror. Make sure you are looking at it honestly — and then make sure you like what you see reflected back.

Part Ten: The Research Frontier — What We Are Still Learning

Hormonal science is not settled. I want to be transparent about where the genuine uncertainties lie, because intellectual honesty matters more to me than a clean narrative.

The question of testosterone and cognitive function is genuinely unsettled. Some research suggests that higher testosterone in older men is associated with better spatial cognition, verbal memory, and processing speed. Other research finds no relationship or even inverse relationships in certain cognitive domains. The Women’s Health Initiative Memory Study analogue for men — a large-scale, long-term trial of testosterone and cognitive outcomes — has not been conducted. The clinical recommendations for testosterone and cognitive health remain provisional.

The cardiovascular safety of long-term TRT is an area of active research and some legitimate controversy. Early studies raised concerns about increased cardiovascular risk, but more recent large-scale research — including the TRAVERSE trial published in 2023, the largest randomized controlled trial of TRT in men with age-related low testosterone — found no significant increase in cardiovascular events compared to placebo, while showing benefits for sexual function, energy, and mood. This is reassuring for appropriately indicated TRT, but does not settle the question for men prescribed testosterone at higher doses or with pre-existing cardiovascular risk factors.

The microbiome-testosterone relationship is an emerging area of interest. Research is documenting bidirectional relationships between gut bacteria composition and sex hormone metabolism. Certain bacteria express enzymes that can recycle estrogen metabolites, and gut dysbiosis has been associated with altered testosterone metabolism in some studies. This research is preliminary but points toward another pathway through which diet and lifestyle influence hormonal health that goes beyond the conventional mechanisms we have discussed.

The neurological effects of testosterone — its role in neuroplasticity, myelin maintenance, and neuroinflammation — are increasingly appreciated but not yet well characterized at the clinical level. Animal research and early human studies suggest testosterone has neuroprotective properties and influences the brain in ways relevant to depression, cognitive aging, and potentially neurodegenerative disease risk. This is a frontier, not a established territory, but it suggests that the long-term consequences of testosterone deficiency and the long-term benefits of appropriate treatment may extend well beyond what we currently measure in clinical trials.

Finally, the genetics of androgen sensitivity — how individual variation in androgen receptor gene expression influences the behavioral and physiological effects of any given testosterone level — is increasingly recognized as clinically important but not yet routinely incorporated into clinical practice. Two men with identical total and free testosterone may have dramatically different androgenic responses based on genetic variation. As genomic medicine matures, individualized hormonal assessment based on receptor genetics is likely to become part of best practice. We are not there yet, but the direction is clear.

Stay curious. The science is moving. The framework I have given you today — the Hormonal Literacy Protocol — is built on the most strong evidence available now. But hold it with the intellectual humility that all scientific frameworks deserve. Update as the evidence updates. That is not weakness. That is the only honest way to navigate a genuinely complex biological system.

This has been episode 326 of Resilient Wisdom. If this conversation was useful to you, share it with someone who is navigating their own hormonal confusion. The gap between what the science shows and what the culture believes about testosterone is enormous, and closing it is work that happens one conversation at a time.

I will see you in the next episode.

Closing Reflection: The Man Who Understood His Own Biology

I want to leave you with a final image. Not a case study from my practice, but a composite portrait of the man who, gets this right — not the man who optimizes his testosterone, but the man who has developed genuine hormonal literacy.

He is not the man in the testosterone clinic advertisement — lean, posed, radiating manufactured vitality. He is a real man navigating a real life. He understands that when he feels flat and unmotivated, the first question is not “what supplement or intervention do I need?” but “what is missing from my life context?” He has built a life with enough genuine challenge that his competitive drive has an outlet. He invests in his relationships with the skill and patience that depth requires. He sleeps like it matters, because it does. He trains because the competitive experience of building strength over time is genuinely good for him, not because he is chasing a physique.

When his energy dips or his drive fades, he does not panic. He reads the signal. What has changed? Am I sleeping? Have I been avoiding challenge? Is there something in my relationships or work environment generating chronic stress? He investigates his own system with the curiosity of a scientist rather than the anxiety of a man who believes his manhood is measured in nanograms per deciliter.

And when something is genuinely wrong — when the investigation of lifestyle factors does not explain the symptoms, when the clinical picture points toward a real biological issue that deserves medical attention — he engages the healthcare system with informed sophistication. He comes with data. He asks the right questions. He takes the treatment that is actually indicated rather than the one that is easiest to prescribe or most aggressively marketed.

He is not a myth. He is a possibility. And the Hormonal Literacy Protocol is the map to becoming him.

Your body is telling you something every day. Learn to listen to it with accuracy. That accuracy — that is the real strength.

The research we covered today spans over three decades and several continents. Dr. Sapolsky’s work on behavioral neuroendocrinology from Stanford has given us the framework of hormones as modulators rather than drivers of behavior. Mazur and Booth’s Challenge Hypothesis research from Syracuse has shown us that testosterone tracks competitive experience, not just biological state. Eisenegger’s placebo research from Zurich has demonstrated that testosterone mythology is itself behaviorally powerful — independent of the hormone. Gettler and Kuzawa’s fatherhood research from Notre Dame and Northwestern has shown us that the male endocrine system is a flexible, socially sensitive apparatus that adapts to role demands. Van Anders’s pair bonding research has mapped the hormonal landscape of intimate connection. Swan’s EDC research has documented the chemical environment’s real impact on male hormonal health. Morgentaler’s clinical work from Harvard has carved out the space for appropriate treatment while warning against the medicalization of normal variation. Mehta’s dual-hormone hypothesis has shown us that testosterone’s behavioral effects are gated by the stress system — you cannot understand one without the other.

Each of these researchers has contributed a piece to a picture that is more detailed, more interesting, and more empowering than the mythology that dominates popular conversation. The picture is this: you have more influence over your own hormonal landscape than you have been led to believe. That influence operates primarily through the quality and character of how you live — the choices you make about challenge, rest, relationship, purpose, and environment. The hormones will follow. They always do.

That is the Hormonal Literacy Protocol. Use it well.


References


Tags


You may also like

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}

Get in touch

Name*
Email*
Message
0 of 350